Welsh, Carson, Anderson & Stowe Raises $4.3 Billion in Oversubscribed Thirteenth Private Equity Fund

San Diego, USA July 2019 – Abzena, the global partner research organization, announced it has successfully completed a technology transfer and scalability evaluation using the Synaffix technologies of GlycoConnect™ (antibody conjugation) and HydraSpace™ (highly polar spacer). Familiarity with these Antibody-Drug Conjugate (ADC) technologies adds to Abzena’s leadership in process development and GM